Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Iron Status and Cause-Specific...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Iron Status and Cause-Specific Mortality After Kidney Transplantation

Iron Status and Cause-Specific Mortality After Kidney Transplantation

Bibliographic Details
Main Authors: Joanna Sophia J. Vinke, MD, Daan Kremer, MD, Tim J. Knobbe, MD, Niels Grote Beverborg, MD, PhD, Stefan P. Berger, MD, PhD, Stephan J.L. Bakker, MD, PhD, Martin H. de Borst, MD, PhD, Michele F. Eisenga, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Kidney Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S259005952300184X
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S259005952300184X

Similar Items

  • Iron Deficiency, Cadmium Levels, and Kidney Transplant Outcomes in Prevalent Kidney Transplant Recipients
    by: Pien Rawee, MSc, et al.
    Published: (2025-02-01)
  • Urinary Endotrophin and Long-term Outcomes in Kidney Transplant Recipients
    by: Firas F. Alkaff, MD, et al.
    Published: (2024-03-01)
  • Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation—The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation
    by: Yohei Yamada, MD, PhD, et al.
    Published: (2018-02-01)
  • Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
    by: Yoshihide Ueda, MD, PhD, et al.
    Published: (2017-12-01)
  • Efficacy and Safety of Allogeneic Islet Transplantation Demonstrated by a Multicenter Clinical Trial in Japan
    by: Takayuki Anazawa, MD, PhD, et al.
    Published: (2025-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs